stockrowCrescent Biopharma, Inc. (CBIO) vs Gyre Therapeutics, Inc. (GYRE)
- Crescent Biopharma, Inc. CBIO 13.60 +0.44%
- Gyre Therapeutics, Inc. GYRE 4.64 −2.52%
Crescent Biopharma, Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and Gyre Therapeutics, Inc. are of similar size ($507.0M and $493.1M). Gyre Therapeutics, Inc. grew revenue faster over the last twelve months: 13.5% against −45.1%. Crescent Biopharma, Inc. has the higher net margin (0.00% vs −21.5%) and the higher return on invested capital (0.00% vs −8.51%). Across the 16 metrics below, Gyre Therapeutics, Inc. leads on 9 and Crescent Biopharma, Inc. on 7.
Valuation
Profitability
| Metric | CBIO | GYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.72% | 91.71% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (21.46%) | 0.00% |
| Free cash flow margin | 0.00% | (19.94%) | 0.00% |
| Return on equity | (101.95%) | (18.54%) | (50.82%) |
| Return on assets | (88.26%) | (14.49%) | (46.04%) |
| Return on invested capital | 0.00% | (8.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack